-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q2 2024.
- Turnstone Biologics Corp. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $2K.
- Turnstone Biologics Corp. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$180K.
- Turnstone Biologics Corp. annual Income Tax Expense (Benefit) for 2023 was -$286K, a 303% decline from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)